- Home
- INDI vs QURE Comparison
INDI vs QURE Comparison
Compare INDI & QURE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INDI
- QURE
- Stock Information
- Founded
- INDI 2007
- QURE 1998
- Country
- INDI United States
- QURE Netherlands
- Employees
- INDI N/A
- QURE N/A
- Industry
- INDI Semiconductors
- QURE Biotechnology: Pharmaceutical Preparations
- Sector
- INDI Technology
- QURE Health Care
- Exchange
- INDI Nasdaq
- QURE Nasdaq
- Market Cap
- INDI 790.2M
- QURE 866.3M
- IPO Year
- INDI N/A
- QURE 2007
- Fundamental
- Price
- INDI $4.38
- QURE $52.91
- Analyst Decision
- INDI Strong Buy
- QURE Strong Buy
- Analyst Count
- INDI 5
- QURE 12
- Target Price
- INDI $5.90
- QURE $69.67
- AVG Volume (30 Days)
- INDI 4.2M
- QURE 7.0M
- Earning Date
- INDI 11-06-2025
- QURE 11-04-2025
- Dividend Yield
- INDI N/A
- QURE N/A
- EPS Growth
- INDI N/A
- QURE N/A
- EPS
- INDI N/A
- QURE N/A
- Revenue
- INDI $217,685,000.00
- QURE $14,337,000.00
- Revenue This Year
- INDI $4.53
- QURE N/A
- Revenue Next Year
- INDI $31.60
- QURE $287.72
- P/E Ratio
- INDI N/A
- QURE N/A
- Revenue Growth
- INDI N/A
- QURE N/A
- 52 Week Low
- INDI $1.53
- QURE $5.03
- 52 Week High
- INDI $5.57
- QURE $60.70
- Technical
- Relative Strength Index (RSI)
- INDI 60.62
- QURE 77.94
- Support Level
- INDI $3.88
- QURE $54.02
- Resistance Level
- INDI $4.17
- QURE $57.57
- Average True Range (ATR)
- INDI 0.23
- QURE 4.16
- MACD
- INDI 0.06
- QURE 2.48
- Stochastic Oscillator
- INDI 84.78
- QURE 83.44
About INDI indie Semiconductor Inc.
Indie Semiconductor Inc is empowering the Autotech revolution with next-generation automotive semiconductors and software platforms. It focuses on edge sensors for Driver Assistance Systems including LiDAR, connected car, user experience, and electrification applications. These technologies represent the core underpinnings of both electric and autonomous vehicles, while the user interfaces transform the in-cabin experience to mirror and seamlessly connect to the mobile platforms. Geographically, the company generates majority of its revenue from Greater China and rest from United States, Europe, South Korea and other regions.
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.